Real-world initiation of continuous glucose monitoring (CGM) in adults with type 1 diabetes leads to increased body mass index - A brief report from IMI-SOPHIA study

IF 2.9 3区医学 Q3 ENDOCRINOLOGY & METABOLISM

Journal of diabetes and its complications Pub Date : 2025-05-24 DOI:10.1016/j.jdiacomp.2025.109089

Jimena Soto-Hernaez , Rory J. McCrimmon , Ewan R. Pearson , Enrique Soto-Pedre

引用次数: 0

Abstract

Continuous glucose monitoring (CGM) has beneficial effects on glycaemic control in adults with type 1 diabetes (T1D), but the potential effects on body mass index (BMI) remain unclear. This study underscores a trend of increasing BMI within two years after CGM initiation.

查看原文本刊更多论文

IMI-SOPHIA研究的一份简短报告：成人1型糖尿病患者在现实世界中开始连续血糖监测（CGM）会导致体重指数增加

持续血糖监测（CGM）对成人1型糖尿病（T1D）的血糖控制有有益作用，但对体重指数（BMI）的潜在影响尚不清楚。这项研究强调了CGM开始后两年内BMI增加的趋势。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of diabetes and its complications 医学-内分泌学与代谢

CiteScore

5.90

自引率

3.30%

发文量

153

审稿时长

16 days

期刊介绍： Journal of Diabetes and Its Complications (JDC) is a journal for health care practitioners and researchers, that publishes original research about the pathogenesis, diagnosis and management of diabetes mellitus and its complications. JDC also publishes articles on physiological and molecular aspects of glucose homeostasis. The primary purpose of JDC is to act as a source of information usable by diabetes practitioners and researchers to increase their knowledge about mechanisms of diabetes and complications development, and promote better management of people with diabetes who are at risk for those complications. Manuscripts submitted to JDC can report any aspect of basic, translational or clinical research as well as epidemiology. Topics can range broadly from early prediabetes to late-stage complicated diabetes. Topics relevant to basic/translational reports include pancreatic islet dysfunction and insulin resistance, altered adipose tissue function in diabetes, altered neuronal control of glucose homeostasis and mechanisms of drug action. Topics relevant to diabetic complications include diabetic retinopathy, neuropathy and nephropathy; peripheral vascular disease and coronary heart disease; gastrointestinal disorders, renal failure and impotence; and hypertension and hyperlipidemia.